A new family of nanocarriers, called ‘3HM,’ has been developed and meets all the size and stability requirements for effectively delivering therapeutic drugs to the brain for the treatment of a deadly form of cancer known as glioblastoma multiforme.
A new family of nanocarriers, called ‘3HM,’ has been developed and meets all the size and stability requirements for effectively delivering therapeutic drugs to the brain for the treatment of a deadly form of cancer known as glioblastoma multiforme.